Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it will host a conference call and live webcast at 8:30 am ET ...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%.
Utidelone, previously received orphan drug designation from the FDA for the treatment of breast cancer brain metastases and gastric cancer. The U.S. Food and Drug Administration (FDA) has reportedly ...
Pancreatic cancer is an aggressive disease, and unlike many other cancers, survival rates have barely improved. Researchers ...
8hon MSN
Cancer breakthrough: Scientists discover protein that could stop tumour growth in the pancreas
Researchers have identified the SPP1 protein as a key driver in the aggressive spread of pancreatic cancer. Blocking SPP1 in lab models dramatically slowed cancer growth and prevented metastasis. This ...
Pancreatic cancer is one of the most aggressive cancer types. A new study from Karolinska Institutet, in collaboration with ...
Pancreatic cancer is one of the most aggressive cancer types. A new study from Karolinska Institutet, in collaboration with ...
A cutting-edge bronchoscope that is guided with the help of a robot can reach very small tumors growing in hard-to-reach ...
For the first time, scientists have identified 27 bacteria and fungi living in our mouths that are implicated in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback